<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7405653\results\search\testTrace\results.xml">
  <result pre="pmcid: 7405653 doi: 10.1590/0037-8682-0517-201900205 : Review Article Update on the" exact="treatment" post="of musculoskeletal manifestations in chikungunya fever: a guideline http://orcid.org/0000-0002-5963-8178de"/>
  <result pre="published intervention studies. In 2016, a multidisciplinary group published pharmacological" exact="treatment" post="protocols for pain in patients with chikungunya, which was"/>
  <result pre="consensus was published by the Brazilian Society of Rheumatology about" exact="diagnosis" post="and treatment. After 5 years of experience with chikungunya"/>
  <result pre="in 21% of these cases. The study suggested that the" exact="prevalence" post="of chronification may be related to the strain of"/>
  <result pre="George AmÃ©rico and 75% in Alto CemitÃ©rio, higher than the" exact="prevalence" post="reported in the literature9. Brazil is a country of"/>
  <result pre="the patients affected with the disease. Suffering related to the" exact="infection" post="is caused by pain and mental, mood, and sleep"/>
  <result pre="importance of the topic, only three guidelines worldwide systematize the" exact="treatment" post="of musculoskeletal disease: the first was published in 2015"/>
  <result pre="consulting review articles, published guidelines, and clinical trials on the" exact="treatment" post="of patients with musculoskeletal manifestations of any kind. The"/>
  <result pre="associated with edema (arthritis) or not. At this stage, the" exact="treatment" post="goal is the relief of acute pain with the"/>
  <result pre="to manage these cases to control symptoms in the initial" exact="treatment" post="stages. In the case of localized or diffuse non-inflammatory"/>
  <result pre="reassessed after 10 days. If the response is good, this" exact="treatment" post="can be maintained for up to 4 weeks, with"/>
  <result pre="making it necessary to associate this therapeutic class with the" exact="treatment" post="after clinical confirmation of the condition. Laboratory tests should"/>
  <result pre="and 37.1% reported having difficulty bathing. Suffering related to CHIKV" exact="infection" post="is not limited to pain; a significant segment of"/>
  <result pre="and evaluating the intensity of inflammation. FIGURE 4: Questionnaire for" exact="diagnosis" post="of neuropathic pain-DN4. The BSR suggests that patients at"/>
  <result pre="should be aware of the adverse effects, typical of each" exact="treatment" post="class prescribed at this stage of treatment and the"/>
  <result pre="typical of each treatment class prescribed at this stage of" exact="treatment" post="and the need for specific clinical and laboratory monitoring"/>
  <result pre="use. For immunosuppressive drugs, specific tests are required, such as" exact="screening" post="for hepatitis B (hepatitis B surface antigen, antibodies to"/>
  <result pre="human immunodeficiency virus, the Mantoux test, and chest x-ray. Physiotherapeutic" exact="treatment" post="is recommended in all three phases of the disease,"/>
  <result pre="ppageshttp://portalarquivos.saude.gov.br/images/pdf/2016/dezembro/25/chikungunya-novo-protocolo.pdf 17MarquesCDLDuarteALBPRanzolinADantasATCavalcantiNGGonÃ§alvesRSGet al.Recommendations of the Brazilian Society of Rheumatology for" exact="diagnosis" post="and treatment of Chikungunya fever Part 1Diagnosis and special"/>
  <result pre="al.Recommendations of the Brazilian Society of Rheumatology for diagnosis and" exact="treatment" post="of Chikungunya fever Part 1Diagnosis and special situationsRev Bras"/>
  <result pre="reviewActa paul. enferm20072019 Dec 02Available from: http://www.scielo.br/scielo.php?script=sci_arttext&amp;amp;pid=S0103-21002007000200001&amp;amp;lng=en. http://dx.doi.org/10.1590/S0103-21002007000200001 20BrightonSWChloroquine phosphate" exact="treatment" post="of chronic Chikungunya arthritis. An open pilot studySouth African"/>
 </snippets>
</snippetsTree>
